SCF-KIT: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 1: Line 1:
'''Stem cell factor (SCF)''' is a cytokine that mediates its diverse cellular responses by binding to and activating the [https://en.wikipedia.org/wiki/Receptor_tyrosine_kinase receptor tyrosine kinase (RTK)] [https://en.wikipedia.org/wiki/CD117 KIT] (also known as SCF receptor). SCF functions as a noncovalent homodimer, and both membrane-anchored and soluble forms of SCF have been described.  
'''Stem cell factor (SCF)''' is a cytokine that mediates its diverse cellular responses by binding to and activating the [https://en.wikipedia.org/wiki/Receptor_tyrosine_kinase receptor tyrosine kinase (RTK)] [https://en.wikipedia.org/wiki/CD117 KIT] (also known as SCF receptor). [https://en.wikipedia.org/wiki/Stem_cell_factor SCF] functions as a noncovalent homodimer, and both membrane-anchored and soluble forms of SCF have been described.  
KIT was initially discovered as an oncogene in a feline retrovirus.
KIT was initially discovered as an oncogene in a feline retrovirus.
SCF and KIT are required for a normal development of hematopoietic cells, melanocytes and others. In humans, loss-of-function mutations in KIT cause the [https://en.wikipedia.org/wiki/Piebald piebald] trait. A variety of gain-of-function mutations in KIT were found in different types of human cancers such as gastro-intestinal-stromal tumors, acute myeloid leukemia, and mast cell leukemia.  
SCF and KIT are required for a normal development of hematopoietic cells, melanocytes and others. In humans, loss-of-function mutations in KIT cause the [https://en.wikipedia.org/wiki/Piebald piebald] trait. A variety of gain-of-function mutations in KIT were found in different types of human cancers such as gastro-intestinal-stromal tumors, acute myeloid leukemia, and mast cell leukemia.